|
Chronic Obstructive Pulmonary Disease |
12851 |
A smoothed version of the Lassosum penalty for fitting integrated risk models |
Georg Hahn |
|
Chronic Obstructive Pulmonary Disease |
16197 |
Allosomal mosaicism (mCA X, loss of Y) chromosome association with COPD phenotypes and lung function |
redld@channing.harvard.edu |
|
Chronic Obstructive Pulmonary Disease |
14727 |
An Investigation of the Allele-Specific Expression in miRNAs |
Jiang Li |
|
Chronic Obstructive Pulmonary Disease |
4649 |
Application of multi-ethnic predictors for PrediXcan analysis of lung function and COPD in TOPMed |
Ani Manichaikul |
|
Chronic Obstructive Pulmonary Disease |
19628 |
Assessing Caveolar Pathway Proteins in COPD Susceptibility |
Ed Silverman |
|
Chronic Obstructive Pulmonary Disease |
9053 |
Assessing the Contribution of Rare Genetic Variants to Chronic Obstructive Pulmonary Disease using Whole-Genome Sequence Data |
Wonji Kim |
|
Chronic Obstructive Pulmonary Disease |
12370 |
Assessment of the Effect of Structural Variants on Pulmonary Function and COPD |
Wonji Kim |
|
Chronic Obstructive Pulmonary Disease |
10683 |
Association of Telomere Length with Chronic Obstructive Pulmonary Disease and Lung Function |
Dandi Qiao |
|
Chronic Obstructive Pulmonary Disease |
16320 |
Associations of FADS (rs174537) with emphysema and chronic lower respiratory disease in Hispanic populations |
John Kim |
|
Chronic Obstructive Pulmonary Disease |
5522 |
Biomarker development and functional validation of lncRNA in pulmonary disease |
Ani Manichaikul |
